These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14656650)

  • 1. [Hepatitis related to amoxicillin or levofloxacin: a case report].
    Heluwaert F; Roblin X; Duffournet V; Capony P; Martin D; Roblin X
    Rev Med Interne; 2003 Dec; 24(12):841-3. PubMed ID: 14656650
    [No Abstract]   [Full Text] [Related]  

  • 2. Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication.
    Gisbert JP; Bermejo MF; Infante JM; Gallardo BP; Bermejo AB; Rodríguez JM; Andrés PR; García GG
    J Clin Gastroenterol; 2009 Apr; 43(4):384-5. PubMed ID: 19020466
    [No Abstract]   [Full Text] [Related]  

  • 3. [Levofloxacin hepatotoxicity].
    Pubill-Fondevila N; Bielsa S; Porcel JM
    Med Clin (Barc); 2013 Mar; 140(6):283. PubMed ID: 22995847
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute hepatitis associated with the use of levofloxacin.
    Figueira-Coelho J; Pereira O; Picado B; Mendonça P; Neves-Costa J; Neta J
    Clin Ther; 2010 Sep; 32(10):1733-7. PubMed ID: 21194596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute cholestatic hepatitis associated with levofloxacin].
    Titos-Arcos JC; Hallal H; Robles M; Andrade RJ
    Gastroenterol Hepatol; 2011 May; 34(5):369-70. PubMed ID: 21477892
    [No Abstract]   [Full Text] [Related]  

  • 6. Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer.
    Ermis F; Akyuz F; Uyanikoglu A; Kurt R; Pinarbasi B; Nazik H; Kaymakoglu S; Mungan Z
    South Med J; 2011 Aug; 104(8):579-83. PubMed ID: 21886067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
    Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E
    Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
    Rokkas T; Sechopoulos P; Robotis J; Pistiolas D
    Am J Gastroenterol; 2006 Aug; 101(8):1938; author reply 1938-9. PubMed ID: 16928256
    [No Abstract]   [Full Text] [Related]  

  • 9. [Levofloxacin hepatotoxicity. Higher risk in diabetics?].
    Coelho J; Gonçalves C; Leitão S; Marques Dos Santos R; Nascimento Costa J
    Acta Med Port; 2011 Dec; 24 Suppl 3():729-34. PubMed ID: 22856423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-induced fever during treatment with levofloxacin: a case-report].
    Grépinet C; Guillocheau E; Berteloot A; Vachée A; Herbin O; Gautier S;
    Therapie; 2008; 63(4):341-3. PubMed ID: 19043827
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection.
    Tursi A; Picchio M; Elisei W
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):133-8. PubMed ID: 22720300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
    Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
    Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxic hepatitis following sequential treatment with cotrimoxazol, levofloxacin, doxycycline and sertraline in a patient with a respiratory infection].
    García-Aparicio J; Herrero-Herrero JI
    Farm Hosp; 2010; 34(3):152-4. PubMed ID: 20471573
    [No Abstract]   [Full Text] [Related]  

  • 15. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
    Gisbert JP; Pérez-Aisa A; Bermejo F; Castro-Fernández M; Almela P; Barrio J; Cosme A; Modolell I; Bory F; Fernández-Bermejo M; Rodrigo L; Ortuño J; Sánchez-Pobre P; Khorrami S; Franco A; Tomas A; Guerra I; Lamas E; Ponce J; Calvet X;
    J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute fatal hepatitis related to levofloxacin.
    Spahr L; Rubbia-Brandt L; Marinescu O; Armenian B; Hadengue A
    J Hepatol; 2001 Aug; 35(2):308-9. PubMed ID: 11580158
    [No Abstract]   [Full Text] [Related]  

  • 17. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
    Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D;
    Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral plantar tendinitis during levofloxacin therapy.
    Beyer J; Schellong S
    Br J Clin Pharmacol; 2006 May; 61(5):609. PubMed ID: 16669855
    [No Abstract]   [Full Text] [Related]  

  • 19. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
    Coban S; Ceydilek B; Ekiz F; Erden E; Soykan I
    Ann Pharmacother; 2005 Oct; 39(10):1737-40. PubMed ID: 16105873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy.
    Gopal Rao G; Mahankali Rao CS; Starke I
    J Antimicrob Chemother; 2003 Mar; 51(3):697-701. PubMed ID: 12615873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.